IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC

NCT04665362 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Advanced/Metastatic Hepatocellular Carcinoma

Interventions

DRUG: Recombinant oncolytic virus M1, anti PD-1 antibody, Apatinib

Sponsor

Liang Peng

Collaborators

[object Object]